Skip to main content
Clinical Trials/CTRI/2011/12/002188
CTRI/2011/12/002188
Recruiting
Phase 4

Comparative Efficacy, Safety and Cost Effectiveness of Lornoxicam with Ibuprofen in Patient with Primary Dysmenorrhoea : A Randomized, Double-Blind, Active-Controlled Study

Government Medical College Bhavnagar0 sites75 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: N944- Primary dysmenorrheaHealth Condition 2: null- primary dysmenorrhoea
Sponsor
Government Medical College Bhavnagar
Enrollment
75
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • ?Healthy women of 18 to 40 years of age groups
  • ?Regular menstrual cycle (21 ? 35 days)
  • ?With moderate or severe pain and self assessment of dysmenorrhoea
  • ?History of primary dysmenorrhoea within 3 to 4 years of menarche
  • ?Willing for non pregnant status during entire study period
  • ?History of at least 6 month of menstrual cramping pain which last for 2 days of each menstrual cycle
  • ?Patient who voluntary participate in the study with signed inform consent

Exclusion Criteria

  • ?Patient having secondary dysmenorrhoea
  • ?Patient having mild menstrual pain
  • ?Patient with any valvular heart disease or acute abdominal condition
  • ?Patient with history of severe gastritis, peptic ulceration or any g.i.t bleeding
  • ?Patient taking regular NSAIDs for some therapeutic indication for pain relief other than menstrual pain
  • ?Patient underwent for some surgical procedure or IUD insertion or injectable contraceptive before the 4 month of study
  • ?Patient allergic to any NSAIDs
  • ?Patient on ACE inhibitors, platelet aggregation inhibitors, diuretics or anti diabetic drugs
  • ?Taking rescue medication within the 1 hour of trial medication during study

Outcomes

Primary Outcomes

Not specified

Similar Trials